Peter Hambleton

2.7k total citations
69 papers, 1.9k citations indexed

About

Peter Hambleton is a scholar working on Molecular Biology, Neurology and Endocrinology. According to data from OpenAlex, Peter Hambleton has authored 69 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 21 papers in Neurology and 13 papers in Endocrinology. Recurrent topics in Peter Hambleton's work include Botulinum Toxin and Related Neurological Disorders (21 papers), Bacillus and Francisella bacterial research (13 papers) and Neurological disorders and treatments (10 papers). Peter Hambleton is often cited by papers focused on Botulinum Toxin and Related Neurological Disorders (21 papers), Bacillus and Francisella bacterial research (13 papers) and Neurological disorders and treatments (10 papers). Peter Hambleton collaborates with scholars based in United Kingdom, United States and Canada. Peter Hambleton's co-authors include J. Melling, Clifford C. Shone, A. Baskerville, R. B. Fitzgeorge, J. Oliver Dolly, M. Broster, P. J. Dennis, R. Stanley Williams, Jane Carman and J. E. Benbough and has published in prestigious journals such as The Lancet, Applied and Environmental Microbiology and Biochemical Journal.

In The Last Decade

Peter Hambleton

67 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Hambleton United Kingdom 23 898 666 337 321 191 69 1.9k
Sabine Pellett United States 26 1.3k 1.4× 698 1.0× 828 2.5× 487 1.5× 233 1.2× 76 2.9k
S. S. Arnon United States 9 1.1k 1.2× 473 0.7× 514 1.5× 107 0.3× 77 0.4× 9 1.6k
Shunji Sugii Japan 23 365 0.4× 797 1.2× 177 0.5× 219 0.7× 409 2.1× 101 1.9k
Junzaburo Minami Japan 25 180 0.2× 637 1.0× 48 0.1× 92 0.3× 321 1.7× 47 1.7k
Claude Lachance Canada 21 151 0.2× 587 0.9× 39 0.1× 46 0.1× 198 1.0× 27 1.9k
E J Hansen United States 42 69 0.1× 1.1k 1.6× 75 0.2× 322 1.0× 654 3.4× 87 4.3k
Eric Morignat France 23 345 0.4× 588 0.9× 140 0.4× 20 0.1× 37 0.2× 57 1.6k
Kachiko Sekiya Japan 18 40 0.0× 493 0.7× 67 0.2× 344 1.1× 107 0.6× 41 1.3k
Drake H. Tilley United States 14 656 0.7× 120 0.2× 80 0.2× 99 0.3× 53 0.3× 26 1.2k
Elisabeth Kugelberg Sweden 18 94 0.1× 796 1.2× 25 0.1× 134 0.4× 287 1.5× 76 1.9k

Countries citing papers authored by Peter Hambleton

Since Specialization
Citations

This map shows the geographic impact of Peter Hambleton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Hambleton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Hambleton more than expected).

Fields of papers citing papers by Peter Hambleton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Hambleton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Hambleton. The network helps show where Peter Hambleton may publish in the future.

Co-authorship network of co-authors of Peter Hambleton

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Hambleton. A scholar is included among the top collaborators of Peter Hambleton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Hambleton. Peter Hambleton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hambleton, Peter, et al.. (2013). JCTB Editorial for January 2014. Journal of Chemical Technology & Biotechnology. 89(1). 1–1. 1 indexed citations
2.
Sharp, Richard & Peter Hambleton. (2001). A Coming of 'Phage: Bacteriophages in Biotechnology. Journal of Chemical Technology & Biotechnology. 76(7). 661–661. 1 indexed citations
3.
Hambleton, Peter. (1994). Botulinum Toxin: Structure and Pharmacology. PubMed. 200–202. 4 indexed citations
4.
Hambleton, Peter. (1994). Clostridium botulinum. Edited by A. H. W. Hauschild & K. L. Dodds, Marcel Dekker, Inc., New York, 1993, vii + 412 pp., price £135.00. ISBN 0 8247 8748 X. Journal of Chemical Technology & Biotechnology. 59(1). 113–113. 1 indexed citations
5.
Shone, Clifford C., et al.. (1993). Proteolytic cleavage of synthetic fragments of vesicle‐associated membrane protein, isoform‐2 by botulinum type B neurotoxin. European Journal of Biochemistry. 217(3). 965–971. 98 indexed citations
6.
Hambleton, Peter, et al.. (1992). Antitoxins and botulinum toxin treatment.. BMJ. 304(6832). 959–960. 43 indexed citations
7.
Hambleton, Peter. (1992). Clostridium botulinum toxins: a general review of involvement in disease, structure, mode of action and preparation for clinical use. Journal of Neurology. 239(1). 16–20. 112 indexed citations
8.
Hambleton, Peter, et al.. (1992). Biosafety monitoring devices for biotechnology processes. Trends in biotechnology. 10(6). 192–199. 10 indexed citations
9.
Hambleton, Peter, et al.. (1991). A high containment polymodal pilot‐plant fermenter—design concepts. Journal of Chemical Technology & Biotechnology. 50(2). 167–180. 1 indexed citations
10.
Wadsworth, Jonathan D. F., Howard S. Tranter, Peter Hambleton, et al.. (1990). Botulinum type F neurotoxin. Large-scale purification and characterization of its binding to rat cerebrocortical synaptosomes. Biochemical Journal. 268(1). 123–128. 31 indexed citations
11.
Melling, J., Peter Hambleton, & Clifford C. Shone. (1988). Clostridium botulinum toxins: nature and preparation for clinical use. Eye. 2(1). 16–23. 71 indexed citations
12.
Tranter, Howard S., et al.. (1988). Studies on the irradiation of toxins of Clostridium botulinum and Staphylococcus aureus. Journal of Applied Bacteriology. 65(3). 223–229. 11 indexed citations
13.
14.
Shone, Clifford C., Peter Hambleton, & J. Melling. (1985). Inactivation of Clostridium botulinum type A neurotoxin by trypsin and purification of two tryptic fragments. European Journal of Biochemistry. 151(1). 75–82. 100 indexed citations
15.
Thornton, Barry, et al.. (1984). Herpes simplex virus genital infection of the female guinea pig as a model for the evaluation of an experimental vaccine. Vaccine. 2(2). 141–148. 15 indexed citations
16.
Baskerville, A., R. B. Fitzgeorge, M. Broster, & Peter Hambleton. (1983). Histopathology of experimental Legionnaires' disease in guinea pigs, rhesus monkeys and marmosets. The Journal of Pathology. 139(3). 349–362. 30 indexed citations
17.
Hambleton, Peter, John Stephenson, A. Baskerville, & C. Wiblin. (1983). Pathogenesis and immune response of vaccinated and unvaccinated rhesus monkeys to tick-borne encephalitis virus. Infection and Immunity. 40(3). 995–1003. 19 indexed citations
18.
Fitzgeorge, R. B., A. Baskerville, M. Broster, Peter Hambleton, & P. J. Dennis. (1983). Aerosol infection of animals with strains ofLegionella pneumophilaof different virulence: comparison with intraperitoneal and intranasal routes of infection. Journal of Hygiene. 90(1). 81–89. 74 indexed citations
19.
Corbel, M.J., et al.. (1983). Biochemical and pathological changes in experimental phycomycosis. Journal of Comparative Pathology. 93(2). 219–234. 6 indexed citations
20.
STRANGE, R. E., et al.. (1972). Methods for the Assessment of Microbial Populations Recovered from Enclosed Aerosols. Journal of General Microbiology. 72(1). 117–125. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sabine Pellett Breakdown of academic impact, for papers by S. S. Arnon Breakdown of academic impact, for papers by Shunji Sugii Breakdown of academic impact, for papers by Junzaburo Minami Breakdown of academic impact, for papers by Claude Lachance Breakdown of academic impact, for papers by E J Hansen Breakdown of academic impact, for papers by Eric Morignat Breakdown of academic impact, for papers by Kachiko Sekiya Breakdown of academic impact, for papers by Drake H. Tilley Breakdown of academic impact, for papers by Elisabeth Kugelberg
Rankless by CCL
2026